KOSDAQ · Healthcare · ₩92B
₩3,170-1.86%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 8.4% · as of 26.10.26
Among 97 제약 peers
Quarterly Revenue Growth
“이번 분기, 사업 확장보다 본업 이익 회복이 먼저예요.”
In the company's words · 2026 2분기 filing